Elyse R Park1, Louisa G Sylvia2, Joanna M Streck3, Christina M Luberto4, Amelia M Stanton2, Giselle K Perez3, Margaret Baim5, Cayley C Bliss6, Mary Susan Convery7, Sydney Crute6, John W Denninger8, Karen Donelan9, Michelle L Dossett10, Maurizio Fava2, Stacie Fredriksson11, Gregory Fricchione8, Nevita George12, Daniel L Hall3, Betsy Remington Hart11, John Herman2, April Hirschberg2, Daphne Holt2, Sara E Looby13, Laura Malloy5, Jocelyn Meek5, Darshan H Mehta14, Rachel A Millstein2, Helen Mizrach6, Katherine Rosa5, Ellen Slawsby5, A Clare Stupinski11, Lara Traeger2, Rachel Vanderkruik2, Christine Vogeli9, Sabine Wilhelm2. 1. Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America; Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA, United States of America. Electronic address: epark@mgh.harvard.edu. 2. Harvard Medical School, Boston, MA, United States of America; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America. 3. Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America. 4. Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America; Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA, United States of America. 5. Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA, United States of America. 6. Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America. 7. Social Service Department, Massachusetts General Hospital, Boston, MA, United States of America. 8. Harvard Medical School, Boston, MA, United States of America; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America; Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA, United States of America. 9. Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America. 10. UC Davis Health, Department of Internal Medicine, Sacramento, CA, United States of America. 11. Home Base Program, Massachusetts General Hospital, Boston, MA, United States of America. 12. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America. 13. Yvonne L. Munn Center for Nursing Research, Massachusetts General Hospital, Boston, MA, United States of America. 14. Harvard Medical School, Boston, MA, United States of America; Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA, United States of America; Home Base Program, Massachusetts General Hospital, Boston, MA, United States of America.
COVID-19 has caused an unprecedented healthcare crisis, which has taken a toll on frontline clinicians (FC) [1,2], The MassGeneral Brigham (MGB) hospital system launched an FC resiliency group program and assessed its feasibility, acceptability, and efficacy. Upon IRB approval, English-speaking FCs were recruited (3/23/20–6/02/20) for 17 groups, and completed optional pre and post-treatment surveys. The treatment, previously assessed in caregivers and clinicians, was grounded in relaxation response elicitation, mindfulness, cognitive behavioral therapy, and positive psychology [3,4] and adapted for FCs (health and job uncertainty, clinical role transitions, isolation, and financial and family challenges). Program delivery was modified to eight 1-h biweekly sessions via a HIPAA compliant synchronous videoconferencing platform. Groups were co-facilitated by MGB staff trained in the Stress Management and Resiliency Training-Relaxation Response Program (SMART-3RP) delivery, offered at flexible times, and organized according to FC specialty. Group facilitators attended biweekly clinical supervision, documented attendance, and completed treatment fidelity checklists. No serious adverse events were reported.Demographics and work characteristics, feasibility (attendance at 6 out of the 8 sessions) and acceptability (program met needs, helpfulness) were assessed. Primary outcomes were assessed by 1–2 items of validated scales: stress reactivity [5], perceived stress coping (0–10 analog), distress [6], and resiliency [7]; and secondary outcomes: loneliness/isolation [8], self-compassion [9], and mindfulness [10]. Descriptive statistics, paired sample t-tests, and Cohen's D were calculated (Stata version 16). Content analyses were conducted (NVivo 12) by 2 independent coders (kappa = 0.92).147 FCs registered, and 102 (69%) completed a baseline assessment. Participants were 92.1% female, 83.3% White, non-Hispanic, 8.8% Asian, 3.9% Black, 9.8% Hispanic and 2% Other. A variety of clinical specialties were represented with the largest groups: Social Workers/Chaplains/Psychologists (24.5%), Respiratory/Physical/Speech Therapists (18.6%), nurses (17.7%), nurse practitioners and physician assistants (15.7%), and physicians (12.8%). 34.3% of participants reported an increase in work hours in the past month, 81.4% reported a change in work setting, and 49.0% reported a change in clinical role.One hundred FCs attended at least one session, and 75% of participants completed both a baseline and end of treatment assessment. Participants completed a mean of 6 sessions; 64% completed >6 sessions. 96% of participants agreed that the program met their needs, and 99% agreed that the program was helpful. Participants' open ended responses revealed that the program structure and sharing with others facing similar workplace-challenges were the most helpful aspects of the group. Positive reappraisal and enhancing social support and connectedness were the skills reported as the most helpful. All outcomes significantly improved (ps < 0.01) (Table 1
) with medium to large effects for all primary outcomes.
Table 1
Pre/post treatment outcomes (n = 75).
Pre M (SD)
Post M (SD)
p-value
Cohen's D
Primary Outcomes (Score Range)
Stress Coping (analog; 0–10)
6.5 (1.5)
7.4 (1.1)
<0.01
0.66
Stress Coping Personal Strengths (MOCS-A; 1–5)
Coping Response
3.3 (0.8)
4.0 (0.7)
<0.01
0.80
Emotionally Balanced Thoughts
3.5 (0.7)
3.9 (0.7)
<0.01
0.50
Resiliency (CES; 0–10)
6.3 (1.4)
7.1 (1.5)
<0.01
0.56
Emotional Distress (PHQ-4; 0–12)
3.9 (2.7)
2.3 (1.9)
<0.01
0.64
Secondary Outcomes
Loneliness/Isolation (UCLA; 2–8)
3.1 (1.1)
2.7 (0.9)
<0.01
0.44
Mindfulness (CAMS-R; 2–8)
5.5 (1.2)
6.1 (1.1)
<0.01
0.55
Self-Compassion (SCS; 1–5)
3.7 (0.9)
3.3 (1.0)
<0.01
0.35
Pre/post treatment outcomes (n = 75).An FC adapted resiliency group program was successfully implemented, across a large hospital system, and decreased COVID-19-associated distress and improved resiliency. Providers were engaged during a public health crisis. Limitations included self-reported outcomes and limited gender diversity. Preserving FC resiliency is of upmost importance during the pandemic and can be achieved through a targeted, accessible group-based treatment.
Funding support
None.We would like to express our gratitude for our team who volunteered their time, at the onset of the pandemic, to assist frontline clinicians.
Authors: Elyse R Park; Giselle K Perez; Rachel A Millstein; Christina M Luberto; Lara Traeger; Jacqueline Proszynski; Emma Chad-Friedman; Karen A Kuhlthau Journal: Matern Child Health J Date: 2020-01
Authors: Darshan H Mehta; Giselle K Perez; Lara Traeger; Elyse R Park; Roberta E Goldman; Vivian Haime; Eva H Chittenden; John W Denninger; Vicki A Jackson Journal: J Pain Symptom Manage Date: 2015-11-06 Impact factor: 3.612
Authors: Helen Mizrach; Brett Goshe; Elyse R Park; Christopher Recklitis; Joseph A Greer; Yuchiao Chang; Natasha Frederick; Annah Abrams; Mary D Tower; Emily A Walsh; Mary Huang; Lisa Kenney; Alan Homans; Karen Miller; John Denninger; Ghazala Naheed Usmani; Jeffrey Peppercorn; Giselle K Perez Journal: JMIR Res Protoc Date: 2022-01-26
Authors: Louisa G Sylvia; Nevita George; Dustin J Rabideau; Joanna M Streck; Evan Albury; Daniel L Hall; Christina M Luberto; Helen R Mizrach; Giselle K Perez; Sydney Crute; Darshan H Mehta; Mary Susan Convery; Sara E Looby; Gregory Fricchione; Maurizio Fava; Sabine Wilhelm; Elyse R Park Journal: J Affect Disord Date: 2021-06-24 Impact factor: 4.839